MSActiveSource

About Biogen Idec

Our Mission

Biogen Idec uses cutting edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders.

Our History

In November 2003, Biogen Idec Inc. (NASDAQ: BIIB) was formed from the merger of two of the world's leading biotechnology companies, Biogen, Inc. and IDEC Pharmaceuticals Corporation. This combination has resulted in a fusion of complementary strengths in therapeutic focus, research and development capabilities, manufacturing expertise, global infrastructure and financial position. Biogen Idec intends to continue its growth through discovery, development and commercialization of its own innovative products and through strategic alliances as the partner-of-choice for biologics development, manufacturing and marketing.

Biogen Idec is dedicated to pursuing the creativity of science. The company's products and development programs address a variety of key medical needs in the areas of oncology, neurology, dermatology and immunology. The company is driven by scientific excellence that achieves new standards of care. Biogen Idec invested nearly 30% of 2006 revenues in Research and Development.

In addition to Biogen Idec's promising portfolio of drug candidates, the company's capabilities and capacity for protein manufacturing are world-class in quality and scale. The company is one of a handful of biotechnology companies that has licensed and dedicated biological bulk-manufacturing facilities, which include its large-scale manufacturing plant in Research Triangle Park, North Carolina, one of the world's largest cell culture facilities, and the world-class 90,000 liter facility for the manufacturing of biologics in Hillerod, Denmark, close to completion of construction.

Biogen Idec is headquartered in Weston, MA and maintains its International headquarters in Zug, Switzerland, with additional centers of excellence Hillerod, DK and Maidenhead, UK. The company also has offices throughout Western and Central Europe, in Brazil, Canada and throughout the Asia Pacific region, including Japan, India, China, Singapore and Australia, and operates a global distribution network which covers over 70 markets.

Biogen Idec in the UK

Our UK head office is in the Berkshire town of Maidenhead, located in southeast England about 20 miles west of Heathrow Airport. Biogen Idec has been conducting business in the UK for more than 10 years. The scope of our operations here has continued to expand and has helped to improve the care of people affected by MS.

Biogen Idec Limited
Innovation House
70 Norden Road
Maidenhead
Berkshire SL6 4AY
United Kingdom

For more information, please visit our corporate UK website.